Company profile: Medrio
1.1 - Company Overview
Company description
- Provider of advanced electronic data capture (EDC) and e-clinical tools for complex clinical trials, offering real-time data access via dynamic reports, exports, and automated casebooks; supply chain optimization for coordinated dispensing aligned with manufacturing, packaging, labeling, and logistics; participant comprehension and engagement solutions; services to accelerate study timelines and improve clinical data integrity.
Products and services
- Improve Clinical Data Integrity: A quality-focused EDC capability that ensures the quality and cleanliness of clinical trial data, maintaining rigorous data integrity.
- Real-Time Clinical Trial Data Access: An EDC-integrated capability that delivers dynamic reports, easy data exports, and automated casebook creation for immediate visibility into trial information.
- Increase Participant Engagement: A web-based product that simplifies participation in clinical trials on any device to increase engagement.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Medrio
Lab Unlimited
HQ: Ireland
Website
- Description: Provider of laboratory instrumentation, consumables, training, service, and validation, with an extensive catalogue available on its website backed by more than 400 manufacturers. Highly trained representatives can recommend solutions, replacements, and cost-saving options.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lab Unlimited company profile →
Comprehend
HQ: United States
Website
- Description: Provider of cloud applications and consulting services that improve the clinical trial process, delivering actionable risk and performance insights across studies, systems, sites, and vendors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Comprehend company profile →
NewLimit
HQ: United States
Website
- Description: Provider of epigenetic reprogramming medicines and technologies to extend human healthspan by restoring youthful function in aging cells and targeting age-related diseases. Offerings include single-cell genomics, machine learning models for experimental prioritization, in silico experimental models, epigenetic editing, and functional genomics screens.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NewLimit company profile →
Florence Healthcare
HQ: United States
Website
- Description: Provider of a clinical trials platform that connects pharmaceutical companies and study sites to decentralize trials for drug development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Florence Healthcare company profile →
Invivodata
HQ: United States
Website
- Description: Provider of electronic patient-reported outcomes (ePRO) solutions and services for clinical trials, offering patient data collection, data management, and clinical outcome assessments software. Offers DiaryPRO electronic patient diary and DiaryPRO Web for PRO data collection via a web interface, and provides SitePRO, helping worldwide clinical trial sponsors assess the effectiveness of new medical products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Invivodata company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Medrio
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Medrio
2.2 - Growth funds investing in similar companies to Medrio
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Medrio
4.2 - Public trading comparable groups for Medrio
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →